Spandana Sphoorty Financial has received markets regulator Securities and Exchange Board...
Bhansali Engineering Polymers has reported results for second quarter ended September 30,...
Bharat Hotels has received markets regulator Securities and Exchange Board of India's (SEBI)...
The US markets ended mostly lower on Friday, while Dow Jones Industrial ekes out marginal...
Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for...
06-Sep2016
Manpasand Beverages 'Mango Sip' brand has emerged as the second highest selling mango drink across all SPAR hypermarkets in India. The brand is available at all of SPAR's 17 outlets spread across 9 locations in India.
The worldwide SPAR organization comprises 12,000 stores in 40 countries on 4 continents and meets the needs of over 13 million consumers every day. SPAR hypermarkets and supermarkets in India is the result of a license agreement between the Dubai based Landmark Group's Max Hypermarkets India and Amsterdam based SPAR International.
Manpasand Beverages is India's only pure play beverage company with a flagship brand, 'Mango Sip'. Its beverage brands are present in 24 states through more than 200,000 retailers, over 2,000 distributors and 200-plus super stockists.
Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......
Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......
Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......
Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......
Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......
Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......